Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNX30 Activators

SNX30 activators encompass a diverse group of chemical compounds that work through various signaling pathways to enhance the functional activity of SNX30, a protein implicated in endosomal sorting and trafficking. One activation mechanism involves the direct stimulation of adenylyl cyclase, leading to elevated cyclic AMP levels, a critical second messenger in cellular signaling. This increase in cAMP, achieved through either adrenergic receptor agonism or inhibition of phosphodiesterases, can potentiate the function of SNX30 in its associated pathways. Another method of activation is through the modulation of cGMP levels, either by promoting its production via nitric oxide-related signaling or by preventing its degradation through selective phosphodiesterase inhibition. The resulting rise in cGMP can similarly facilitate SNX30's role in the endocytic pathway by influencing downstream protein kinases that govern cargo sorting.

Moreover, activators that alter intracellular calcium dynamics offer an indirect route to modulate SNX30 activity. By increasing cytosolic calcium concentrations, either by facilitating its influx or by inhibiting its sequestration into organelles, these compounds can trigger calcium-dependent signaling cascades that intersect with SNX30-mediated processes. This modulation of calcium signaling is capable of influencing the intricate network of interactions and functions in which SNX30 is involved, particularly those related to the dynamic regulation of endosomal sorting and trafficking.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A non-selective beta-adrenergic agonist that elevates cAMP levels, potentially enhancing SNX30 function in endosomal sorting.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Phosphodiesterase inhibitor that prevents cAMP breakdown, possibly leading to improved SNX30-mediated signaling.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Selective phosphodiesterase-4 inhibitor, increases cAMP levels thereby potentially increasing SNX30 activity in cells.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Activates G protein-coupled receptors coupled to cAMP production, which may amplify SNX30 driven endosomal processes.

(±)-S-Nitroso-N-acetylpenicillamine

79032-48-7sc-200319B
sc-200319
sc-200319A
10 mg
20 mg
100 mg
$74.00
$114.00
$374.00
18
(3)

Releases nitric oxide which activates guanylyl cyclase, increasing cGMP that may indirectly support SNX30 endosomal function.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

A cAMP analog that activates PKA, potentially enhancing the role of SNX30 in endosomal sorting and trafficking.

8-Bromo-cGMP

51116-01-9sc-200316
sc-200316A
10 mg
50 mg
$104.00
$354.00
7
(1)

A cGMP analog that can activate PKG, possibly facilitating SNX30's involvement in endosomal cargo sorting and trafficking.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Ionophore that increases intracellular calcium, potentially triggering SNX30-mediated endosomal sorting via calcium signaling.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA pump inhibitor leading to increased cytosolic calcium, which may indirectly enhance SNX30 function in cargo sorting.